Inventor · disambiguated record
Jan Scicinski
Also filed as: SCICINSKI JAN · SCICINSKI JAN J · SCICINSKI JAN JOZEF
16 granted patents·10 pending applications·134 citations·filing 2005–2023
94Inventor score
Top patents by PatentIndex Score
26 records- 0197US9987270B1Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2016·Granted Jun 5, 2018·16 cites·35 claims
- 0296US9468625B2Organonitro thioether compounds and medical uses thereofEPICENTRX INC·Filed 2015·Granted Oct 18, 2016·15 cites·20 claims
- 0394US11701351B2Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2021·Granted Jul 18, 2023·2 cites·20 claims
- 0494US8664247B2Acyclic organonitro compounds for use in treating cancerSCICINSKI JAN·Filed 2012·Granted Mar 4, 2014·17 cites·13 claims
- 0593US11008287B2Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicineEPICENTRX INC·Filed 2017·Granted May 18, 2021·9 cites·19 claims
- 0692US10543208B2Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2018·Granted Jan 28, 2020·12 cites·12 claims
- 0791US10342778B1Treatment of brain metastases using organonitro compound combination therapyEPICENTRX INC·Filed 2016·Granted Jul 9, 2019·13 cites·30 claims
- 0890US9139519B2Organonitro thioether compounds and medical uses thereofSCICINSKI JAN·Filed 2012·Granted Sep 22, 2015·18 cites·24 claims
- 0989US11576895B2Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanoneEPICENTRX INC·Filed 2017·Granted Feb 14, 2023·4 cites·19 claims
- 1089US9616055B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2015·Granted Apr 11, 2017·7 cites·17 claims
- 1188US11160784B1Treatment of brain metastases using organonitro compound combination therapyEPICENTRX INC·Filed 2019·Granted Nov 2, 2021·8 cites·19 claims
- 1286US11660286B2Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood productsEPICENTRX INC·Filed 2019·Granted May 30, 2023·3 cites·6 claims
- 1384US9884056B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Feb 6, 2018·3 cites·16 claims
- 1483US10328068B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Jun 25, 2019·2 cites·20 claims
- 1580US12357607B2Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanoneEPICENTRX INC·Filed 2022·Granted Jul 15, 2025·0 cites·37 claims
- 1677US7842707B2Peptidase inhibitorsNUADA LLC·Filed 2005·Granted Nov 30, 2010·5 cites·20 claims
- 1773US2024374562A1Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood productsEPICENTRX INC·Filed 2023·Application pending·0 cites
- 1868US2010260844A1Oral pharmaceutical dosage formsSCICINSKI JAN J·Filed 2009·Application pending·0 cites
- 1966US2020000791A1Oral pharmaceutical dosage formsDURECT CORP·Filed 2019·Application pending·0 cites
- 2062US2020375982A1Treatment of gliomas using organonitro compound combination therapyEPICENTRX INC·Filed 2019·Application pending·0 cites
- 2161US2014011842A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2013·Application pending·0 cites
- 2246US2009264384A1Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereofNUADA INC·Filed 2008·Application pending·0 cites
- 2345US2018369232A1Composite Nanoparticles And Uses ThereofLOS GATOS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2445US2012149678A1Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating TheretoORONSKY BRYAN T·Filed 2011·Application pending·0 cites
- 2540US2014308260A1Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood productsRADIORX INC·Filed 2012·Application pending·0 cites
- 2635US2008319044A1Compounds and Methods of Use ThereofNUADA LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Scicinski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →